Related Experiment Video
Updated: Jul 4, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma
Samera H Hamad1,2,3, Rani S Sellers1,4, Nathan Wamsley5
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
Abstract:
Aberrant activation of the NRF2/NFE2L2 transcription factor commonly occurs in head and neck squamous cell carcinomas (HNSCC). Mouse model studies have shown that NRF2 activation alone does not result in cancer. When combined with classic oncogenes and at the right dose, NRF2 activation promotes tumor initiation and progression. Here we deleted the tumor suppressor genes p16INK4A and p53 (referred to as CP mice), which are commonly lost in human HNSCC, in the presence of a constitutively active NRF2E79Q mutant (CPN mice). NRF2E79Q expression in CPN mice resulted in squamous cell hyperplasia or dysplasia with hyperkeratosis in the esophagus, oropharynx, and forestomach. In addition, CPN mice displayed oral cavity squamous cell carcinoma (OSCC); CP mice bearing wild-type NRF2 expression did not develop oral cavity hyperplasia, dysplasia or OSCC. In both CP and CPN mice, we also observed predominantly abdominal sarcomas and carcinomas. Our data show that in the context of p53 and p16 tumor suppressor loss, NRF2 activation serves oncogenic functions to drive OSCC. CPN mice represent a new model for OSCC that closely reflects the genetics of human HNSCC.
Significance:
Human squamous cancers frequently show constitutive NRF2 activation, associated with poorer outcomes and resistance to multiple therapies. Here, we report the first activated NRF2-driven and human-relevant mouse model of squamous cell carcinoma that develops in the background of p16 and p53 loss. The availability of this model will lead to a clearer understanding of how NRF2 contributes to the initiation, progression, and therapeutic response of OSCC.
Insights
Constitutive activation of the NRF2 (NFE2L2) transcription factor drives oral cavity squamous cell carcinoma (OSCC) in mice lacking p53 and p16 tumor suppressors. This new model mimics human HNSCC genetics, aiding OSCC research.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Aberrant activation of the NRF2 (Nuclear factor erythroid 2-related factor 2) transcription factor is common in head and neck squamous cell carcinomas (HNSCC).
- NRF2 activation alone does not cause cancer but promotes tumor initiation and progression when combined with oncogenes.
- Loss of tumor suppressor genes p16INK4A and p53 is frequently observed in human HNSCC.
Purpose of the Study:
- To investigate the oncogenic role of NRF2 in the context of p16 and p53 loss in HNSCC.
- To develop a novel, human-relevant mouse model for oral cavity squamous cell carcinoma (OSCC).
Main Methods:
- Deletion of p16INK4A and p53 tumor suppressor genes in mice (CP mice).
- Introduction of a constitutively active NRF2E79Q mutant in CP mice (CPN mice).
- Histopathological analysis of tumor development in the esophagus, oropharynx, forestomach, and oral cavity.
Main Results:
- CPN mice developed squamous cell hyperplasia, dysplasia, and OSCC in the oral cavity.
- CP mice with wild-type NRF2 did not develop oral cavity lesions.
- Both CP and CPN mice developed abdominal sarcomas and carcinomas.
- NRF2 activation drives OSCC in the context of p53 and p16 loss.
Conclusions:
- NRF2 acts as an oncogene in driving OSCC when p53 and p16 tumor suppressors are lost.
- CPN mice provide a new, genetically relevant model for studying OSCC initiation, progression, and therapeutic response.
More Related Videos
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Ras Gene
Ras is a...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...